Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis
======================================================================================================================================

* Richard S P Huang
* David P Carbone
* Gerald Li
* Alexa Schrock
* Ryon P Graf
* Liangliang Zhang
* Karthikeyan Murugesan
* Jeffrey S Ross
* Khaled Tolba
* Jacob Sands
* Geoffrey R Oxnard
* David Spigel